Article
Injunctions Against Sale Of Lingaliptin
The plaintiff is a multinational company involved in the production and manufacture of pharmaceutical drugs and had acquired patent rights for its products under Indian Patent Nos. 243301 and 227719.
Khurana & Khurana, Advocates and IP Attorneys




